Dr. Jami A. Fukui
Claim this profileKapiolani Medical Center for Women and Children
Area of expertise
Breast Cancer
Jami A. Fukui has run 10 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Jami A. Fukui has run 4 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Kapiolani Medical Center For Women And Children
Hawaii Cancer Care Inc - Waterfront Plaza
Clinical Trials Jami A. Fukui is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
FDG-PET/CT Scan Prediction
for Breast Cancer
This trial tests an imaging procedure in patients with a specific type of breast cancer. The test uses a small amount of radioactive sugar to highlight active cancer areas, helping doctors decide if more or less treatment is needed before surgery. This imaging procedure has been used successfully for diagnosis, initial staging, restaging, early treatment response assessment, evaluation of disease spread, and predicting outcomes in breast cancer.
Recruiting
1 award
Phase 2
17 criteria
More about Jami A. Fukui
Clinical Trial Related
6 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Jami A. Fukui has experience with
- Fludeoxyglucose F-18
- Tucatinib
- Tamoxifen
- Letrozole
- Exemestane
- Educational Intervention
Breakdown of trials Jami A. Fukui has run
Breast Cancer
Breast cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jami A. Fukui specialize in?
Jami A. Fukui focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Jami A. Fukui currently recruiting for clinical trials?
Yes, Jami A. Fukui is currently recruiting for 5 clinical trials in Honolulu Hawaii. If you're interested in participating, you should apply.
Are there any treatments that Jami A. Fukui has studied deeply?
Yes, Jami A. Fukui has studied treatments such as Fludeoxyglucose F-18, Tucatinib, Tamoxifen.
What is the best way to schedule an appointment with Jami A. Fukui?
Apply for one of the trials that Jami A. Fukui is conducting.
What is the office address of Jami A. Fukui?
The office of Jami A. Fukui is located at: Kapiolani Medical Center for Women and Children, Honolulu, Hawaii 96826 United States. This is the address for their practice at the Kapiolani Medical Center for Women and Children.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.